generalized anxiety disorder

Generalized Anxiety Disorder (GAD) is a chronic mental health condition characterized by persistent, excessive, and uncontrollable worry regarding a wide array of everyday events, activities, or life domains, such as work, school, and personal relationships DSM-5 essential feature excessive anxiety about multiple domains. Unlike situational anxiety, the worry associated with GAD is often disproportionate to the actual threat and occurs more days than not for a period of at least six months APA as excessive anxiety and worry. This condition significantly impairs an individual's social, occupational, and emotional functioning clinically significant impairment.

The diagnostic criteria for GAD, as outlined in the DSM-5, require the presence of at least three physical or cognitive symptoms, including restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance DSM-5 symptom criteria. ICD-10 criteria similarly emphasize a combination of apprehension and autonomic arousal, requiring at least four symptoms from a broader list of 22 ICD-10 GAD symptoms. A critical component of the diagnosis is the exclusion of other medical conditions—such as hyperthyroidism—substance-induced symptoms, or other primary mental health disorders like panic disorder or social anxiety GAD exclusion criteria per NIHR Journals Library. Clinical assessment often utilizes validated tools such as the GAD-7 scale to measure severity GAD-7 validation.

Epidemiologically, GAD is a prevalent condition, with estimates of U.S. lifetime prevalence ranging from 3.1% to 6.2% U.S. GAD prevalence 6.2% lifetime. While it can affect individuals across the lifespan, onset often occurs in adulthood, with a median age around 25 to 30 AAFP. The disorder is more frequently diagnosed in women and is notably comorbid with other conditions such as depression and panic disorder in nearly 60% of cases News-Medical.net. In older adults, GAD is the most common anxiety disorder, though its presentation and severity can evolve with age late-life onset stats.

Treatment for GAD typically involves a combination of psychotherapy and pharmacotherapy. Cognitive-Behavioral Therapy (CBT) is widely considered the most supported psychological intervention, focusing on techniques such as worry time scheduling, problem-solving, and mindfulness to reduce physical symptoms and cognitive distortions CBT top treatment CBT efficacy unmatched. While some sources suggest CBT is highly effective, others note that GAD can be treatment-resistant, with varying rates of long-term improvement CBT symptom reduction least responsive anxiety disorder. First-line pharmacological treatments include SSRIs and SNRIs, such as escitalopram and venlafaxine, which are often used in conjunction with or as an alternative to therapy SSRIs/SNRIs first-line. Benzodiazepines are generally avoided for long-term management due to risks of dependence ACA. Effective management requires a holistic approach that accounts for cultural factors, social determinants of health, and potential structural barriers to care cultural impacts on GAD.